How much is VerImmune worth in 2026?

VerImmune has a current valuation of $30.0M based on their Later Stage VC round and secondary market data.

How much funding has VerImmune raised?

VerImmune has raised $10.0M in total funding across 1 funding rounds.

VerImmune

Website

VerImmune valuation and funding history | Last updated: July 9, 2025 | 1 funding rounds

Current Valuation

$30.0M

As of July 9, 2025

Total Funding Raised

$10.0M

Across 1 round

Last Round

Later Stage VC

$4.5M

Last Funding

Jul 2025

Funding date

Capital Efficiency

2.99x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
N/A	Unknown	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

VerImmune is currently valued at $30.0M as of July 9, 2025. The company has raised a total of $10.0M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 2.99x, VerImmune has achieved a valuation that is 2.99 times the total capital raised.

Track VerImmune Valuation Updates

Get notified when VerImmune raises new funding or valuation changes

Explore More Data

Detailed analysis for VerImmune

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock VerImmune's valuation history, funding rounds, and growth metrics.

No credit card required

What is VerImmune Worth in 2026?

VerImmune is a leading private company in the technology sector. Track VerImmune's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How VerImmune Valuation is Determined

Private company valuations like VerImmune's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.